SCHEMBL3350812

SCHEMBL3350812

CC(=O)CCc1csc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.58
IDO1 P14902 1/20 0.50
MTNR1A P48039 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
TP53 P04637 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
PKM P14618 1/20 0.49
TAAR1 Q96RJ0 1/20 0.47
ALDH1A1 P00352 3/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CMA1 P23946 1/20 0.45
POLB P06746 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15574186 0.90 CYP2A6 (0.54) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL1393298 0.85 CYP2A6 (0.59) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL8905373 0.83 CYP2A6 (0.58) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL30138881 0.83 CYP2A6 (0.58) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL1393034 0.83 CYP2A6 (0.58) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL12174999 0.83 CYP2A6 (0.61) CYP2A6SMN1; SMN2TP53RXFP1PKM
SCHEMBL6999394 0.83 CYP2A6 (0.53) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL8786755 0.80 CYP4F2 (0.60) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL28693243 0.80 CYP2A6 (0.53) CYP2A6IDO1MTNR1ASMN1; SMN2TP53
SCHEMBL760833 0.80 MTNR1A (0.67) CYP2A6IDO1MTNR1ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010053388-A1 NEW 4,6-DISUBSTITUTED 2-(4-METHYLPIPERAZIN-1-YL)PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, THEIR USE, A METHOD FOR MODULATING MONOAMINERGIC RECEPTOR ACTIVITY AND A MONOAMINERGIC RECEPTOR MODULATING AGENT INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK (PL) 2010-05-14 WO disclosed